Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity
International Journal of Nanomedicine · مج Volume 15 · 7861-7875 · 2020
الملخّص
Purpose: The topically administered drugs through conventional delivery systems have low bioavailability. Henceforth, the present study was designed to prepare and optimize clarithromycin (CTM)-loaded chitosan nanoparticles (CHNPs) to demonstrate the efficacy against microorganisms. Methods: Clarithromycin-loaded chitosan nanoparticles (CTM-CHNPs) were prepared by ionotropic gelation method. The formulation was optimized by box-Behnken design using the formulation variables like CH (A), STPP concentration (B), and stirring speed (C). Their effects were evaluated on the independent variables like particle size (Y 1 ) and entrapment efficiency (Y 2 ). Further, CTM-CHNPs were evaluated for physicochemical parameters, in-vitro drug release, ex-vivo permeation, bioadhesive study, corneal hydration, histopathology, HET-CAM, and antibacterial study. Results: The optimized formulation (CTM-CHNPopt) showed the low particle size (152± 5 nm), which is desirable for ocular delivery. It also showed high encapsulation (70.05%), zeta potential (+35.2 mV), and was found in a spherical shape. The drug release study revealed a sustained drug release profile (82.98± 3.5% in 12 hours) with Korsmeyer peppas kinetic (R 2 =0.996) release model. It showed a 2.7-fold higher corneal permeation than CTM-solution. CHNPs did not exhibit any sign of damage to excised goat cornea, which is confirmed by hydration, histopathology, and HET-CAM test. It exhibited significant ( P < 0.05) higher antibacterial susceptibility than CTM-solution. Conclusion: The finding of the study concluded that CTM-CHNPs can be used for effective management of bacterial conjunctivitis by increasing the precorneal residence time. Keywords: clarithromycin, chitosan, optimization, nanoparticles, HET-CAM, antimicrobial assessment
التفاصيل
- المجلة
- International Journal of Nanomedicine
- الناشر
- Dove Medical Press
- المجلد
- Volume 15
- العدد
- —
- الصفحات
- 7861-7875
- الترقيم الدولي ISSN
- 1176-9114
- السنة
- 2020
- اللغة
- en
- الترخيص
- cc-by-nc
- الوصول المفتوح
- gold
- الاستشهادات
- 72
- المصدر
- scopus
الكلمات المفتاحية
الموضوعات
Advanced Drug Delivery Systems (Pharmacology, Toxicology and Pharmaceutics) · Ocular Infections and Treatments (Medicine) · Nanoparticle-Based Drug Delivery (Materials Science)
استشهد بهذا
Bin-Jumah, M. N., Gilani, S. J., Jahangir, M. A., Zafar, A., Alshehri, S., Yasir, M., Kala, C., Taleuzzaman, M., Imam, S. S. (2020). Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity. International Journal of Nanomedicine, Volume 15, 7861-7875. https://doi.org/10.2147/ijn.s269004
Bin-Jumah, M. N., Gilani, S. J., Jahangir, M. A., Zafar, A., Alshehri, S., Yasir, M., Kala, C., Taleuzzaman, M., Imam, S. S. 2020, 'Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity', International Journal of Nanomedicine, vol. Volume 15, 7861-7875. Available at: https://doi.org/10.2147/ijn.s269004
Bin-Jumah MN, Gilani SJ, Jahangir MA, Zafar A, Alshehri S, Yasir M, Kala C, Taleuzzaman M, Imam SS. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity. International Journal of Nanomedicine. 2020;Volume 15, 7861-7875.
@article{bin-jumah20203045,
title = {Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity},
author = {May Nasser Bin-Jumah and Sadaf Jamal Gilani and Mohammed Asadullah Jahangir and Ameeduzzafar Zafar and Sultan Alshehri and Mohd Yasir and Chandra Kala and Mohamad Taleuzzaman and Syed Sarim Imam},
year = {2020},
journal = {International Journal of Nanomedicine},
volume = {Volume 15},
pages = {7861-7875},
publisher = {Dove Medical Press},
doi = {10.2147/ijn.s269004},
url = {https://doi.org/10.2147/ijn.s269004}
}TY - JOUR AU - May Nasser Bin-Jumah AU - Sadaf Jamal Gilani AU - Mohammed Asadullah Jahangir AU - Ameeduzzafar Zafar AU - Sultan Alshehri AU - Mohd Yasir AU - Chandra Kala AU - Mohamad Taleuzzaman AU - Syed Sarim Imam TI - Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity PY - 2020 JO - International Journal of Nanomedicine VL - Volume 15 SP - 7861-7875 DO - 10.2147/ijn.s269004 UR - https://doi.org/10.2147/ijn.s269004 ER -
